» Authors » Sarah Kabbani

Sarah Kabbani

Explore the profile of Sarah Kabbani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 685
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huynh C, Gouin K, Hicks L, Kabbani S, Neuburger M, McDonald E
J Am Dent Assoc . 2025 Mar; PMID: 40047737
Background: Dentists play a role in combatting antimicrobial resistance. This analysis characterizes antibiotic prescribing changes by dentists after the American Dental Association's dental infection treatment guideline was released in 2019....
2.
Leung V, Ashiru-Oredope D, Hicks L, Kabbani S, Aloosh M, Armstrong I, et al.
JAC Antimicrob Resist . 2024 Dec; 6(6):dlae187. PMID: 39698503
Objective: To explore the role of local public health organisations in antimicrobial stewardship (AMS) and antimicrobial resistance (AMR) surveillance. Methods: A scoping review was conducted. Peer-reviewed and grey literature from...
3.
Gouin K, Creasy S, Beckerson M, Wdowicki M, Hicks L, Kabbani S
Antimicrob Steward Healthc Epidemiol . 2024 Dec; 4(1):e209. PMID: 39654589
Long-term care pharmacy dispensing data from 2013 to 2021 were used to characterize antibiotic prescribing data in U.S. long-term care facilities. Overall antibiotic prescribing rates decreased from 2013 to 2021,...
4.
Hatfield K, Kabbani S, See I, Currie D, Kim C, Jacobs Slifka K, et al.
JAMA Netw Open . 2024 Nov; 7(11):e2446842. PMID: 39589743
Importance: Multiplex molecular syndromic panels for diagnosis of urinary tract infection (UTI) lack clinical data supporting their use in routine clinical care. They also have the potential to exacerbate inappropriate...
5.
Bizune D, Gouin K, Powell L, Hersh A, Hicks L, Kabbani S
Antimicrob Steward Healthc Epidemiol . 2024 Nov; 4(1):e193. PMID: 39483328
We updated a descriptive analysis of national outpatient antibiotic prescribing during the COVID-19 pandemic. Prescribing volume was lower during 2020 and January-June in 2021 and 2022 compared to corresponding baseline...
6.
Kim C, Bartoces M, Gouin K, McDonald E, Hicks L, Kabbani S
Am J Epidemiol . 2024 Oct; PMID: 39367708
No abstract available.
7.
Vazquez Deida A, Bizune D, Kim C, Sahrmann J, Sanchez G, Hersh A, et al.
Open Forum Infect Dis . 2024 Aug; 11(8):ofae420. PMID: 39100530
Background: Better understanding differences associated with antibiotic prescribing for acute sinusitis can help inform antibiotic stewardship strategies. We characterized antibiotic prescribing patterns for acute sinusitis among commercially insured adults and...
8.
Happe M, Hofstetter A, Wang J, Yamshchikov G, Holman L, Novik L, et al.
NPJ Vaccines . 2024 Mar; 9(1):67. PMID: 38553525
Ebola virus disease (EVD) is a filoviral infection caused by virus species of the Ebolavirus genus including Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). We investigated the safety and immunogenicity...
9.
King L, Andrejko K, Kabbani S, Tartof S, Hicks L, Cohen A, et al.
J Infect Dis . 2024 Mar; 230(4):821-831. PMID: 38498565
Background: In 2022-2023, 15- and 20-valent pneumococcal conjugate vaccines (PCV15/PCV20) were recommended for infants. We aimed to estimate the incidence of outpatient visits and antibiotic prescriptions in US children (≤17...
10.
McCarthy N, Baggs J, Wolford H, Kazakova S, Kabbani S, Attell B, et al.
Infect Control Hosp Epidemiol . 2024 Feb; 45(6):726-732. PMID: 38351597
Objective: The 2014 US National Strategy for Combating Antibiotic-Resistant Bacteria (CARB) aimed to reduce inappropriate inpatient antibiotic use by 20% for monitored conditions, such as community-acquired pneumonia (CAP), by 2020....